- Home
- Software Solutions
- Resources
- Corporate
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals Clinical Studies by Phase of Development
Active Clinical Trials 
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Active | Cancer Pain | >Sublingual Sufentanil NanoTab (ARX-F02) | Phase_II | A Study for the Evaluatio... | NCT00833040 |
Completed Clinical Trials
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Completed | Unilateral Knee Replacement | >Sublingual dosage of sufentanil | Phase_II | An Open-Label Functionali... | NCT00859313 |
| Completed | Acute Pain | >Oral Sufentanil >Placebo | Phase_II | Evaluate the Clinical Eff... | NCT00612534 |
| Completed | Major Upper or Lower Abdominal Surgery | >Oral sufentanil >Placebo | Phase_II | A Multicenter, Randomized... | NCT00718081 |
| Completed | Sedation Anxiety Pain | >Sublingual Sufentanil/Triazolam NanoTab™ (ARX-F03) >Placebo NanoTab™ | Phase_II | A Study to Evaluate the C... | NCT00894699 |